Prednisone Terminated Phase 2 Trials for Lymphoma, B-Cell / Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01925612Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT02531308Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)